Laurynas Mockeliunas

A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis

de Jager, Veronique; Mockeliunas, Laurynas; You, Huifang; Simonsson, Ulrika S. H. et al.

Part of Clinical Infectious Diseases, 2025

• DOI for A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis
• Download full text (pdf) of A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis

Pharmacometric efficacy and safety evaluations within the fields of pulmonary tuberculosis and COVID-19

Mockeliunas, Laurynas

2025

• Download full text (pdf) of Pharmacometric efficacy and safety evaluations within the fields of pulmonary tuberculosis and COVID-19

Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic

Mockeliunas, Laurynas; Van Wijk, Rob C; Upton, Caryn M.; Peter, Jonathan et al.

Part of Vaccines, 2024

• DOI for Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic
• Download full text (pdf) of Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic

Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19

Van Wijk, Rob C; Mockeliunas, Laurynas; van den Hoogen, Gerben; Upton, Caryn M. et al.

Part of Scientific Reports, 2023

• DOI for Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19
• Download full text (pdf) of Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

Mockeliunas, Laurynas; Faraj, Alan; Van Wijk, Rob C; Upton, Caryn M. et al.

Part of Frontiers in Pharmacology, 2023

• DOI for Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development
• Download full text (pdf) of Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis

de Jager, Veronique; Mockeliunas, Laurynas; You, Huifang; Simonsson, Ulrika S. H. et al.

Part of Clinical Infectious Diseases, 2025

• DOI for A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis
• Download full text (pdf) of A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis

Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic

Mockeliunas, Laurynas; Van Wijk, Rob C; Upton, Caryn M.; Peter, Jonathan et al.

Part of Vaccines, 2024

• DOI for Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic
• Download full text (pdf) of Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic

Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19

Van Wijk, Rob C; Mockeliunas, Laurynas; van den Hoogen, Gerben; Upton, Caryn M. et al.

Part of Scientific Reports, 2023

• DOI for Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19
• Download full text (pdf) of Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

Mockeliunas, Laurynas; Faraj, Alan; Van Wijk, Rob C; Upton, Caryn M. et al.

Part of Frontiers in Pharmacology, 2023

• DOI for Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development
• Download full text (pdf) of Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

Keutzer, Lina; Mockeliunas, Laurynas; Sturkenboom, Marieke G. G.; Bolhuis, Mathieu S. et al.

Part of Pharmaceuticals, 2023

• DOI for Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment
• Download full text (pdf) of Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling

Van Wijk, Rob C; Mockeliunas, Laurynas; Upton, Caryn M. M.; Peter, Jonathan et al.

Part of CPT, p. 1250-1261, 2023

• DOI for Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling
• Download full text (pdf) of Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis

Mockeliunas, Laurynas; Keutzer, Lina; Sturkenboom, Marieke G. G.; Bolhuis, Mathieu S. et al.

Part of Pharmaceutics, 2022

• DOI for Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
• Download full text (pdf) of Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis

Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double- blind, randomised, controlled, phase 3 trial

Upton, Caryn M.; Van Wijk, Rob C; Mockeliunas, Laurynas; Simonsson, Ulrika S. H. et al.

Part of eClinicalMedicine, 2022

• DOI for Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double- blind, randomised, controlled, phase 3 trial
• Download full text (pdf) of Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double- blind, randomised, controlled, phase 3 trial

Pharmacometric efficacy and safety evaluations within the fields of pulmonary tuberculosis and COVID-19

Mockeliunas, Laurynas

2025

• Download full text (pdf) of Pharmacometric efficacy and safety evaluations within the fields of pulmonary tuberculosis and COVID-19